Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cancer. 2012 Sep 15;118(18):4538-44. doi: 10.1002/cncr.27439. Epub 2012 Feb 22.
The purpose of this study was to assess what factors influence radiation therapy (RT) utilization in patients with glioblastoma and to ascertain how patterns of care have changed over time.
A total of 9103 patients with supratentorial glioblastoma in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2006 were analyzed. Demographic information was obtained, including age, sex, race, year of diagnosis, and marital status. Treatment characteristics included receipt of RT and surgical resection.
In total, 76.8% of patients received RT, whereas 78% received resection. Patients of male sex, who were currently married, who were <65 years old, and who underwent resection were more likely to receive RT. The average annual percentage change in RT utilization in the years 1990-2006 was -0.41% (95% confidence interval [CI], -0.23 to -0.58), whereas for resection it was 0.26% (95% CI, 0.03 to 0.50). This equates to a 6.5% decrease in RT utilization and a 4.2% increase in resection during this time period. Patients treated with RT had a 2-year overall survival of 11.4%, compared with 5.2% in those not treated with RT (P < .00001). Multivariate analysis showed that younger age (continuous; odds ratio [OR], 0.97; P < .0001), marital status (OR, 1.62; P < .0001), surgical resection (OR, 1.72; P < .0001), and year of diagnosis 1998-2006 compared with 1990-1997 (OR, 0.82; P < .0001) were associated with RT utilization, whereas sex, lesion size, and race were not.
SEER data show a decreasing utilization of RT in patients with glioblastoma from 1990 to 2006. Patients who were older, who were unmarried, and who underwent biopsy only were less likely to receive RT.
本研究旨在评估影响胶质母细胞瘤患者接受放疗(RT)的因素,并确定随着时间的推移,治疗模式发生了哪些变化。
分析了 1973 年至 2006 年间监测、流行病学和最终结果(SEER)数据库中 9103 例幕上胶质母细胞瘤患者的资料。获取了包括年龄、性别、种族、诊断年份和婚姻状况在内的人口统计学信息。治疗特征包括接受 RT 和手术切除。
共有 76.8%的患者接受了 RT,而 78%的患者接受了切除。男性、已婚、<65 岁和接受切除的患者更有可能接受 RT。1990-2006 年 RT 使用率的年平均百分比变化为-0.41%(95%置信区间,-0.23%至-0.58%),而切除率为 0.26%(95%置信区间,0.03%至 0.50%)。这相当于在此期间 RT 使用率下降了 6.5%,切除率上升了 4.2%。接受 RT 治疗的患者 2 年总生存率为 11.4%,而未接受 RT 治疗的患者为 5.2%(P<0.00001)。多因素分析显示,年龄较小(连续;比值比[OR],0.97;P<0.0001)、已婚(OR,1.62;P<0.0001)、手术切除(OR,1.72;P<0.0001)以及诊断年份为 1998-2006 年(OR,0.82;P<0.0001)与 RT 使用率相关,而性别、病变大小和种族则无相关性。
SEER 数据显示,1990 年至 2006 年胶质母细胞瘤患者接受 RT 的比例逐渐下降。年龄较大、未婚和仅接受活检的患者接受 RT 的可能性较小。